| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 0.46 | 0.49 | 14.43 | 0.25 | 0.07 | 0.06 | 2.83 |
| Depreciation & Amort ($Mil): | 0.09 | 0.09 | 0.11 | 0.10 | 0.10 | 0.09 | 0.09 |
| Operating Income ($Mil): | -13.57 | -8.58 | 5.98 | -9.20 | -12.16 | -5.95 | -3.71 |
| Net Income ($Mil): | -12.98 | -7.58 | 2.79 | -9.65 | -12.01 | -3.81 | -3.81 |
| Earnings Per Share ($): | -0.41 | -0.30 | 0.13 | -0.50 | -0.70 | -0.54 | -0.51 |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 23.45 | 31.00 | 22.20 | 9.34 | 17.57 | 9.31 | 5.54 |
| Current Liabilities ($Mil): | 3.62 | 1.51 | 4.30 | 2.66 | 1.90 | 0.88 | 1.25 |
| Long Term Debt ($Mil): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Outstanding (000): | 26800 | 26790 | 22980 | 19010 | 18950 | 13550 | 8570 |
| Common Equity ($Mil): | 20.70 | 29.72 | 18.07 | 6.81 | 15.92 | 8.68 | 4.62 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -2821.74 | -1546.94 | 19.33 | -3860.00 | -17157.14 | -9916.67 | -134.63 |
| Return on Equity (%): | -78.20 | -25.50 | 15.44 | -141.70 | -75.44 | -68.55 | -82.47 |
| Return on Assets (%): | -69 | -24.26 | 12.47 | -100.84 | -67.40 | -62.24 | -64.80 |
| P/E Ratio: | 0 | -14.37 | 476.38 | -110.50 | -61.49 | -53.35 | 0.00 |
| Price/Book: | 4 | 3.89 | 78.76 | 154.23 | 51.23 | 44.97 | 0.00 |
| Debt Equity: | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage: | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book Value ($): | 0.77 | 1.11 | 0.79 | 0.36 | 0.84 | 0.64 | 0.54 |
| Price/Sales: | 210.49 | 110.11 | 98.62 | 4201.21 | 11651.54 | 6506.26 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN | +12.60 | 58.23 | |
| GILEAD SCIENCES | -1.00 | 46.92 | |
| CELGENE CP | -10.00 | 58.86 | |
| BIOGEN IDEC INC | -31.90 | 43.52 | |
| AMYLIN PHARMA I | -85.70 | 6.41 |
